Chino CA 抑郁症临床试验
5项针对 抑郁症的研究正在 Chino及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
招募中2 期
- Seaport Investigator Site, Chino
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Chino
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
招募中2 期
- Clinical Research Site, Chino
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Chino
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
招募中3 期
- Inland Pyschiatric Medical Group - Chino /ID# 278667, Chino
其他城市的 抑郁症试验
- Boston, MA50 项研究
- New York City, NY44 项研究
- Chicago, IL26 项研究
- Atlanta, GA22 项研究
- Pittsburgh, PA22 项研究
- Philadelphia, PA21 项研究
- Charleston, SC18 项研究
- San Diego, CA18 项研究
- Houston, TX18 项研究
- Los Angeles, CA17 项研究
- Washington, DC16 项研究
- San Francisco, CA15 项研究
Chino的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。